12.4 million patients develop a new cancer every year and cancer causes 7.6 million death a year. These figures are set to double by 2030. Better caring and curing cancer is a major stake for patients and their relatives, for the society as a whole and also for medical communities, national health systems, drug industry and medicines agencies.

Medical images and data extracted from them play a key role in Oncology: at routine level, imaging data enable to evaluate whether a cancer patient develops a positive response to his or her treatment; at research level, they are instrumental in the development of new cancer drugs and innovative therapeutic schemes.

MEDIAN Technologies provides a complete offer of products and services for diagnosing and monitoring cancer patients from medical images. MEDIAN's offer is targeted to clinical development and to the daily radiological practice in Oncology as well.

Based on cutting-edge image processing technologies, our software products make imaging data more reliable, less reader-dependent. In parallel, efficient and well-targeted imaging workflows and their associated services guarantee an optimized data distribution among patient care specialists as well as among the various stakeholders involved in clinical trials. Thus in clinical trials and in clinical routine, imaging data become real decision-making tools.

Our goal is to make image interpretation an objective reproducible science and to create new perspectives for cancer follow up, for the benefit of the patients